Alison Galvani, PhD
Burnett and Stender Families Professor of Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health; Director of the Center for Infectious Disease Modeling and Analysis (CIDMA)
Research & Publications
Biography
News
Locations
Research Summary
Professor Galvani's research focuses on integrating epidemiology and the evolutionary ecology or economics in order to generate predictions that could not be made by these disciplines alone. This interdisciplinary approach has widespread potential for answering evolutionary questions, explaining empirical observations and informing public health policy. Professor Galvani has applied modeling and cost-effectiveness analyses to improve national and international public health policies of influenza, TB and HPV, HIV, rotavirus and Ebola, among other diseases.
Extensive Research Description
Professor Galvani's research focuses on integrating epidemiology and the evolutionary ecology or economics in order to generate predictions that could not be made by these disciplines alone. This interdisciplinary approach has widespread potential for answering evolutionary questions, explaining empirical observations and informing public health policy. Professor Galvani has applied modeling and cost-effectiveness analyses to improve national and international public health policies of influenza, TB and HPV, HIV, rotavirus and Ebola, among other diseases.
Coauthors
Research Interests
Acquired Immunodeficiency Syndrome; Africa, Southern; Ecology; Economics; Epidemiologic Methods; Epidemiology; Biological Evolution; HIV; Influenza, Human; Parasitology; Public Health; Tuberculosis; Global Health; Evolution, Planetary; Infectious Disease Medicine
Public Health Interests
Epidemiology Methods; Global Health; Health Care Management; Health Policy; Infectious Diseases; Maternal & Child Health; Modeling; COVID-19
Research Image
Dogs and their owners wait in line for canine rabies vaccination during a campaign in northwest Tanzania
We showed that canine rabies vaccination was both an epidemiologically effective and economically cost-effective approach to protect people from rabies transmission (Fitzpatrick et al 2014 Annals of Internal Medicine).
Selected Publications
- The Impact of Enhanced Screening and Treatment on Hepatitis C in the United StatesDurham DP, Skrip LA, Bruce RD, Vilarinho S, Elbasha EH, Galvani AP, Townsend JP. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States. Clinical Infectious Diseases 2015, 62: 298-304. PMID: 26628566, PMCID: PMC4706637, DOI: 10.1093/cid/civ894.
- Impact of bed capacity on spatiotemporal shifts in Ebola transmissionTownsend JP, Skrip LA, Galvani AP. Impact of bed capacity on spatiotemporal shifts in Ebola transmission. Proceedings Of The National Academy Of Sciences Of The United States Of America 2015, 112: 14125-14126. PMID: 26518509, PMCID: PMC4655579, DOI: 10.1073/pnas.1518484112.
- Strategies to prevent future Ebola epidemicsFallah M, Skrip LA, d'Harcourt E, Galvani AP. Strategies to prevent future Ebola epidemics. The Lancet 2015, 386: 131. PMID: 26194388, DOI: 10.1016/s0140-6736(15)61233-8.
- Reassessment of HIV-1 Acute Phase Infectivity: Accounting for Heterogeneity and Study Design with Simulated CohortsBellan SE, Dushoff J, Galvani AP, Meyers LA. Reassessment of HIV-1 Acute Phase Infectivity: Accounting for Heterogeneity and Study Design with Simulated Cohorts. PLOS Medicine 2015, 12: e1001801. PMID: 25781323, PMCID: PMC4363602, DOI: 10.1371/journal.pmed.1001801.
- Strategies for containing Ebola in West AfricaPandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, Nyenswah TG, Ndeffo-Mbah ML, Galvani AP. Strategies for containing Ebola in West Africa. Science 2014, 346: 991-995. PMID: 25414312, PMCID: PMC4316831, DOI: 10.1126/science.1260612.
- Ethical Alternatives to Experiments with Novel Potential Pandemic PathogensLipsitch M, Galvani AP. Ethical Alternatives to Experiments with Novel Potential Pandemic Pathogens. PLOS Medicine 2014, 11: e1001646. PMID: 24844931, PMCID: PMC4028196, DOI: 10.1371/journal.pmed.1001646.
- Social Factors in EpidemiologyBauch CT, Galvani AP. Social Factors in Epidemiology. Science 2013, 342: 47-49. PMID: 24092718, PMCID: PMC4229037, DOI: 10.1126/science.1244492.
- Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in AfricaMbah M, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 7952-7957. PMID: 23589884, PMCID: PMC3651507, DOI: 10.1073/pnas.1221396110.
- Using Game Theory to Examine Incentives in Influenza Vaccination BehaviorChapman GB, Li M, Vietri J, Ibuka Y, Thomas D, Yoon H, Galvani AP. Using Game Theory to Examine Incentives in Influenza Vaccination Behavior. Psychological Science 2012, 23: 1008-1015. PMID: 22810166, DOI: 10.1177/0956797612437606.
- Dengue vector control strategies in an urban setting: an economic modelling assessmentLuz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP. Dengue vector control strategies in an urban setting: an economic modelling assessment. The Lancet 2011, 377: 1673-1680. PMID: 21546076, PMCID: PMC3409589, DOI: 10.1016/s0140-6736(11)60246-8.
- Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?Bauch CT, Li M, Chapman G, Galvani AP. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? The Lancet Infectious Diseases 2010, 10: 133-137. PMID: 20113982, DOI: 10.1016/s1473-3099(10)70004-9.
- Optimizing Influenza Vaccine DistributionMedlock J, Galvani AP. Optimizing Influenza Vaccine Distribution. Science 2009, 325: 1705-1708. PMID: 19696313, DOI: 10.1126/science.1175570.
- Averting epidemics of extensively drug-resistant tuberculosisBasu S, Friedland GH, Medlock J, Andrews JR, Shah NS, Gandhi NR, Moll A, Moodley P, Sturm AW, Galvani AP. Averting epidemics of extensively drug-resistant tuberculosis. Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: 7672-7677. PMID: 19365076, PMCID: PMC2678614, DOI: 10.1073/pnas.0812472106.
- Integrating epidemiology, psychology, and economics to achieve HPV vaccination targetsBasu S, Chapman GB, Galvani AP. Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proceedings Of The National Academy Of Sciences Of The United States Of America 2008, 105: 19018-19023. PMID: 19015536, PMCID: PMC2596236, DOI: 10.1073/pnas.0808114105.
- Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimumGalvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proceedings Of The National Academy Of Sciences Of The United States Of America 2007, 104: 5692-5697. PMID: 17369367, PMCID: PMC1838447, DOI: 10.1073/pnas.0606774104.
- Dimensions of superspreadingGalvani AP, May RM. Dimensions of superspreading. Nature 2005, 438: 293-295. PMID: 16292292, PMCID: PMC7095140, DOI: 10.1038/438293a.
- Evaluating plague and smallpox as historical selective pressures for the CCR5-Δ32 HIV-resistance alleleGalvani AP, Slatkin M. Evaluating plague and smallpox as historical selective pressures for the CCR5-Δ32 HIV-resistance allele. Proceedings Of The National Academy Of Sciences Of The United States Of America 2003, 100: 15276-15279. PMID: 14645720, PMCID: PMC299980, DOI: 10.1073/pnas.2435085100.
- Ecological and immunological determinants of influenza evolutionFerguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature 2003, 422: 428-433. PMID: 12660783, DOI: 10.1038/nature01509.
- Epidemiology meets evolutionary ecology.Galvani, A.P. (2003) Trends in Ecology & Evolution 18: 132-139.